The activation of GPER signaling is effective in reducing the expression of IL-6, but not the viability and proliferation of hepatoma cells, suggesting that GPER action against hepatic tumorigenesis occurs through the regulation of inflammatory response rather than the direct modulation of tumor growth and invasion (351). This evidence concerns the gene GPER1 and neoplasm.